raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:592

Macrophagic myofasciitis

Synonyms: MMF

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adolescent, Adult, Childhood, Elderly
Status
active

A rare acquired skeletal muscle disease characterized by infiltration of the epimysium, perimysium, and perifascicular endomysium by macrophages with crystal inclusions composed of aluminum salts at the site of a previous vaccination (most commonly the deltoid muscle). Muscle necrosis is typically absent. Patients may present with myalgias, arthralgias, muscle weakness, chronic fatigue, asthenia, fever, and cognitive dysfunction. Signs and symptoms usually develop slowly over several months.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enMacrophagic myofasciitisMMF
frMyofasciite à macrophagesMFM · MMF
deMakrophagische Myofasziitis= en
esMiofascitis macrofágica
itMiofascite macrofagicaMMF · Sindrome autoimmune/infiammatoria indotta da granuloma persistente da alluminio
nlMacrofagische myofasciitis= en
ptMiofasceíte macrofágica
plMakrofagowe zapalenie powięzi i mięśniMMF · Zespół autozapalenia/zespół zapalny indukowany adjuwantem z przetrwałego ziarniniaka aluminiowego
csMakrofagická myofasciitidaMMF · Autoimunní/zánětlivé onemocnění indukované adjuvancií s perzistujícími hliníkovými granulomaty
ukМакрофагальний міофасцит= en
zh巨噬细胞肌筋膜炎= en
trMakrofajik miyofasit= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10M60.8NTBTattributedvalidated
MONDO0018942Evalidated
MeSHC537829Evalidated
UMLSC2931639Evalidated
GARD176Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

6 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002829Arthralgia
HP:0012378Fatigue
HP:0001945Fever
HP:0003324Generalized muscle weakness
HP:0003326Myalgia
Occasional (29-5%)
HP:0003457EMG abnormality

Run the differential on the 5 obligate / very frequent terms

7

Sources for this card